J&J, AstraZeneca explore COVID-19 vaccine modification after blood clot reports - WSJ

Johnson & Johnson and AstraZeneca are conducting early-stage research into whether potential modifications to their COVID-19 vaccines could reduce or eliminate the risk of rare but serious blood clots linked to the shots, the Wall Street Journal reported, citing people close to the process.